Potential Benefits Drive Interest in Continuous Manufacturing

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-05-15-2014
Volume 2014 eBook
Issue 2

Players across the biologics value chain are attracted by the advantages of continuous biopharmaceutical manufacturing.

Players across the biologics value chain are attracted by the advantages of continuous biopharmaceutical manufacturing.

Download

Pharmaceutical Technology’s 2014 Bioprocessing and Sterile Manufacturing eBook

.

 

 

 

 

 

 

 

 

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.
Related Content